Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.
|Original language||English (US)|
|Number of pages||6|
|State||Published - Sep 2004|
- B-type natriuretic peptide
- Heart failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine